Key Statistics for 000919
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CNY) (ttm)
|Est. EPS (CNY) (12/2013)
|Est. PEG Ratio
|Market Cap (M CNY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CNY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 000919
- Net Income (M/CNY)
Jinling Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products. The Company's products include the Mailuoning injection for the treatment of arteries and veins, as well as traditional Chinese and western pharmaceutical preparations.
More Company Profile & Key Executives for 000919
|Shen ZhilongChairman||Li ChunminPresident|
|Tang WeiguoExec Vice President||Yin JianbiaoVice President|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.